OGF
BLRX

Orin Green Financial’s BioLineRX BLRX Stock Holding History

Orin Green Financial’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,075
Closed -$15.9K – 79
2024
Q3 		$23.1K Hold
1,075
– – 0.01% 82
2024
Q2 		$24.5K Buy
+1,075
New +$28.9K 0.01% 76

Other funds holding BLRX

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Orin Green Financial's BLRX Position: Q4 2024 in Review

Orin Green Financial sold out of BioLineRX (BLRX) in Q4 2024, closing a stake of 1,075 shares — an estimated $15.9K sold.

Orin Green Financial first reported a position in BLRX in Q2 2024 and held it in 2 quarters. The position peaked at $24.5K in Q2 2024. 31 funds tracked by Wall St. Rank hold BLRX as of Q4 2024.

  • Orin Green Financial reported no remaining BioLineRX position as of Q4 2024 after selling out during the quarter.
  • Orin Green Financial sold 1,075 BioLineRX shares in Q4 2024, an estimated $15.9K.
  • Orin Green Financial first reported a position in BioLineRX in Q2 2024 and held it in 2 quarters.
  • Orin Green Financial's BioLineRX position peaked at $24.5K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q4 2024.

Based on Orin Green Financial's 13F filing for Q4 2024, filed 19 Feb 2025.